Best Stocks to Buy in June for Long-Term Upside: Veeva Systems

Veeva is on the verge of a technical breakout. The beaten-down biopharma software firm's growth outlook is strong, and it's a cash cow with a stellar balance sheet.

Zacks Investment Research • 20 hours ago

Baron Asset Fund Q1 2026 Contributors, Detractors And Recent Activity

SpaceX is generating significant value with the rapid expansion of its Starlink broadband service. CoStar Group's shares fell due to multiple compression driven by rising fears about the potential impact of AI on the company's business.

Seeking Alpha • Jun 1, 2026

Unveiling Veeva (VEEV) Q1 Outlook: Wall Street Estimates for Key Metrics

Get a deeper insight into the potential performance of Veeva (VEEV) for the quarter ended April 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks Investment Research • May 29, 2026

Veeva vs. IQVIA: Which Life Sciences Tech Stock Holds More Promise?

VEEV and IQV are benefiting from life sciences digitization trends, but differences in growth, AI adoption and valuation set them apart.

Zacks Investment Research • May 29, 2026

Veeva Quality Cloud Advances Manufacturing Operations for Kindeva

Global CDMO will unify sites on single quality platform for greater efficiency and scalability PLEASANTON, Calif., May 28, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Kindeva is adopting Veeva Quality Cloud to modernize its manufacturing operations, bringing together its global network of sites onto a single cloud platform.

PRNewsWire • May 28, 2026

Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It

Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks Investment Research • May 28, 2026

Veeva Systems: Patience Required

Veeva faces a critical Q1 earnings report after a 29% YTD share decline, with growth stabilization and AI progress in focus. VEEV's transition from Salesforce to Vault CRM and expansion of Crossix and the AI-driven Falcon platform are key strategic pivots. Guidance implies confidence: Q1 revenue $855–$858M, FY27 revenue $3.585–$3.60B, 44% margin, and strong free cash flow yield at 5.6%.

Seeking Alpha • May 29, 2026

Merck KGaA, Darmstadt, Germany Selects Veeva Vault CRM Worldwide

Agentic CRM with deep industry-specific capabilities provides commercial foundation for the future PLEASANTON, Calif., May 27, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Merck KGaA, Darmstadt, Germany, has committed globally to Veeva Vault CRM.

PRNewsWire • May 27, 2026

Veeva Announces Falcon, an Agentic Platform and Standard Agents to Deliver Agentic Labor in Drug Development

Veeva Falcon works with Veeva clinical, regulatory, and safety applications to increase speed and lower costs PLEASANTON, Calif., May 27, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Falcon, an agentic platform and standard agents for life sciences' major drug development processes.

PRNewsWire • May 27, 2026

Teva Pharmaceuticals Commits to Veeva Vault CRM

Agentic CRM with industry-specific AI for deeper customer engagement PLEASANTON, Calif., May 27, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Teva Pharmaceuticals has committed to Veeva Vault CRM globally.

PRNewsWire • May 27, 2026